AVNS (STOCKS)
Avanos Medical, Inc.
$24.630000
+10.100000 (+69.51%)
Prev close: $14.530000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- David C. Pacitti
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,145.49M
- Employees
- 2,227
- P/E (TTM)
- -9.22
- P/B (TTM)
- 0.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $699.90M |
| Benefits Costs and Expenses | $1.19B |
| Cost Of Revenue | $334.00M |
| Costs And Expenses | $1.19B |
| Gross Profit | $365.90M |
| Operating Expenses | $848.50M |
| Selling, General, and Administrative Expenses | $316.50M |
| Research and Development | $22.90M |
| Other Operating Expenses | $509.10M |
| Operating Income/Loss | -$482.60M |
| Income/Loss From Continuing Operations After Tax | -$468.60M |
| Income/Loss From Continuing Operations Before Tax | -$487.90M |
| Income/Loss From Discontinued Operations Net Of Tax | -$300.00K |
| Income Tax Expense/Benefit | -$19.30M |
| Net Income/Loss | -$468.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$468.90M |
| Net Income/Loss Available To Common Stockholders, Basic | -$468.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$10.19 |
| Diluted Earnings Per Share | -$10.19 |
| Basic Average Shares | 46,300,000 |
| Diluted Average Shares | 45,800,000 |
| Assets | $1.07B |
| Current Assets | $351.40M |
| Accounts Receivable | $111.50M |
| Inventory | $150.60M |
| Other Current Assets | $89.30M |
| Noncurrent Assets | $716.30M |
| Fixed Assets | $115.40M |
| Intangible Assets | $122.00M |
| Other Non-current Assets | $478.90M |
| Liabilities | $289.70M |
| Current Liabilities | $147.90M |
| Accounts Payable | $54.20M |
| Other Current Liabilities | $93.70M |
| Noncurrent Liabilities | $141.80M |
| Long-term Debt | $93.40M |
| Other Non-current Liabilities | $48.40M |
| Equity | $778.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $778.00M |
| Liabilities And Equity | $1.07B |
| Net Cash Flow From Operating Activities | $104.40M |
| Net Cash Flow From Operating Activities, Continuing | $104.40M |
| Net Cash Flow From Investing Activities | -$61.40M |
| Net Cash Flow From Investing Activities, Continuing | -$61.40M |
| Net Cash Flow From Financing Activities | -$61.70M |
| Net Cash Flow From Financing Activities, Continuing | -$61.70M |
| Exchange Gains/Losses | $200.00K |
| Net Cash Flow | -$18.50M |
| Net Cash Flow, Continuing | -$18.70M |
| Comprehensive Income/Loss | -$464.60M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$464.60M |
| Other Comprehensive Income/Loss | -$464.60M |
| Other Comprehensive Income/Loss Attributable To Parent | $4.30M |